Researcher.Life Logo

Molecular Diversity : Impact Factor & More

eISSN: 1573-501XpISSN: 1381-1991

Aims and Scope of Molecular Diversity

Molecular Diversity is a quarterly peer-reviewed scientific journal published by Springer Science+Business Media covering research on molecular diversity and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full-length papers, perspectives, news, and reviews. Coverage addresses the generation of molecular diversity, application of diversity for screening against alternative targets of all types, and the analysis of results and their applications. The journal was established in 1995 and the editors-in-chief are Hong-yu Li and Kunal Roy. Less

Key Metrics

CiteScore
4.1
Impact Factor
< 5
SJR
Q3Catalysis
SNIP
0.79
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Molecular Diversity

Molecular Diversity Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Molecular Diversity ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Molecular Diversity

Identification and validation of natural product-based KRASG12D inhibitors through structure-based virtual screening, molecular dynamics simulation, and in vitro studies.
  • 26 Apr 2026
  • Molecular diversity
AI-driven discovery of natural product-derived FAK1 inhibitors for idiopathic pulmonary fibrosis.
  • 26 Apr 2026
  • Molecular diversity
Rational scaffold discovery for HIV-1 reverse transcriptase inhibitors via integrated in silico approaches.
  • 26 Apr 2026
  • Molecular diversity
Novel organophosphorus-quinolone hybrids as potential antimicrobial agents: design, synthesis, biological evaluation, and in vivo antibacterial effect in bacteria-infected zebrafish model.
  • 26 Apr 2026
  • Molecular diversity
In silico discovery of natural and synthetic inhibitors targeting AKT1 in prostate cancer.
  • 26 Apr 2026
  • Molecular diversity
Subtractive proteomics-driven identification of AgrA and structure-guided discovery of phytochemical and marine natural products as novel anti-quorum sensing therapeutic leads against Enterococcus faecium.
  • 26 Apr 2026
  • Molecular diversity
Identification and validation of natural product-based KRASG12D inhibitors through structure-based virtual screening, molecular dynamics simulation, and in vitro studies.
  • 26 Apr 2026
  • Molecular diversity
AI-driven discovery of natural product-derived FAK1 inhibitors for idiopathic pulmonary fibrosis.
  • 26 Apr 2026
  • Molecular diversity
Rational scaffold discovery for HIV-1 reverse transcriptase inhibitors via integrated in silico approaches.
  • 26 Apr 2026
  • Molecular diversity
Novel organophosphorus-quinolone hybrids as potential antimicrobial agents: design, synthesis, biological evaluation, and in vivo antibacterial effect in bacteria-infected zebrafish model.
  • 26 Apr 2026
  • Molecular diversity
In silico discovery of natural and synthetic inhibitors targeting AKT1 in prostate cancer.
  • 26 Apr 2026
  • Molecular diversity
Subtractive proteomics-driven identification of AgrA and structure-guided discovery of phytochemical and marine natural products as novel anti-quorum sensing therapeutic leads against Enterococcus faecium.
  • 26 Apr 2026
  • Molecular diversity

FAQs on Molecular Diversity